Broadcom named strategic vendor for Walmart virtualization solutions
DAVIDSON, N.C. - Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, announced the acquisition of Lead Fluid, a China-based manufacturer specializing in fluid-handling products. This move is part of Ingersoll Rand’s strategy to expand its life science capabilities within the region. The acquisition adds to Ingersoll Rand’s robust market presence, with the company currently maintaining a market capitalization of $32.7 billion and generating $7.28 billion in revenue over the last twelve months.
Lead Fluid, known for its peristaltic and syringe pumps, gear pumps, and pump heads, caters to life science applications that require precise fluid delivery and sterile conditions. The company’s addition is expected to enhance Ingersoll Rand’s Life Sciences platform within the Precision and Science Technologies segment, contributing approximately $8 million in annual revenue. According to InvestingPro data, Ingersoll Rand maintains a healthy financial position with a current ratio of 2.38, indicating strong liquidity to support its expansion strategy.
Vicente Reynal, chairman and CEO of Ingersoll Rand, stated, "This acquisition demonstrates our ability to work directly with family founders to add leading companies to Ingersoll Rand." He emphasized the strategic fit of Lead Fluid in the company’s portfolio, highlighting its strong domestic brand and reputation in China. InvestingPro analysis shows the company’s solid financial health with an overall score of "GOOD," though it currently trades at a relatively high P/E ratio of 39.65. InvestingPro subscribers have access to 10 additional key insights about Ingersoll Rand’s valuation and growth prospects.
Ingersoll Rand’s approach to growth through acquisitions aligns with its in-region, for-region strategy, aiming to strengthen its market position and increase exposure to high-growth, sustainable markets.
The company, which operates under 80+ respected brands, is known for its products and services that perform in harsh and complex conditions. Ingersoll Rand prides itself on its commitment to making life better for its employees, customers, shareholders, and the planet.
The financial terms of the acquisition were not disclosed, but the company mentioned that the purchase multiple of pre-synergy Adjusted EBITDA is in the low double-digits. With revenue growth of 5.27% over the last twelve months and analyst coverage showing mixed sentiment, investors seeking deeper insights can access comprehensive analysis through InvestingPro’s detailed research reports, which offer expert analysis on over 1,400 US stocks, including Ingersoll Rand.
The information in this article is based on a press release statement. It should be noted that forward-looking statements in the release are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. These statements are not guarantees of future performance and are identified by words such as "believe," "expect," "may," and similar expressions. Factors that could influence Ingersoll Rand’s performance include natural disasters, pandemics, geopolitical tensions, and other unforeseen events.
In other recent news, Ingersoll Rand reported its first-quarter 2025 earnings, which fell slightly short of analyst expectations. The company posted an adjusted earnings per share (EPS) of $0.72, missing the forecast by $0.01, and reported revenue of $1.72 billion, just below the expected $1.73 billion. Despite the earnings miss, Ingersoll Rand achieved a record Q1 free cash flow of $223 million and noted strong order growth with a book-to-bill ratio of 1.1x. The company deferred approximately $15 million in revenue to the second quarter. On the credit front, Fitch Ratings upgraded Ingersoll Rand’s Long-Term Issuer Default Rating to ’BBB+’ from ’BBB’, citing the company’s strong business portfolio and effective financial management. Fitch anticipates that Ingersoll Rand will maintain its EBITDA margins in the high 20% range, supported by new product development and operational efficiencies. The company continues to focus on acquisitions, having recently completed the significant acquisition of ILC Dover, which has expanded its presence in the life sciences and aerospace markets.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.